Purchase Order N0025922P0279
Award Date
8/23/22
Potential Completion Date
3/31/23
Potential Value
$745K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Bureau of Medicine and Surgery
Awardee
Gen-Probe Incorporated
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Japan
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of 250 APTIMA SARS-CoV-2 assay test kits, 30 APTIMA SARS-CoV-2 controls, and 76 Fusion specimen lysis tubes. The total potential value of the award is $239,790.00. The purchase order was not set aside and supports the government's Coronavirus COVID-19 response efforts. Gen-Probe Incorporated is a provider of molecular diagnostic testing...
This contract award to Gen-Probe Incorporated, a medical diagnostics company, is for the APTIMA SARS-COV-2 ASSAY, a product to detect COVID-19, for the Defense Health Agency. The firm-fixed-price purchase order has a potential value of $249,560.00 and a completion date of May 12, 2022. The contract does not have a set-aside designation. Gen-Probe Incorporated, through its Gen-Probe Sales & Service, Inc. division, has previously provided a variety of medical products and services to federal...
This is a $158,550.00 Firm Fixed Price Delivery Order contract awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company. The contract is for the provision of COVID-19 assays, with an ultimate completion date of January 15, 2021. Gen-Probe is a prime contractor that has held numerous contracts with defense and civilian agencies, primarily supplying testing kits, reagents, and equipment for detecting infectious diseases. This award is not associated...
This federal contract award to Gen-Probe Incorporated, a medical diagnostics company, was issued by the Defense Health Agency. The $552,691.20 firm fixed-price delivery order is for the APTIMA SARS-CoV-2 ASSAY, a COVID-19 testing kit under the Emergency Use Authorization (EUA). The contract has no set-aside designation and is scheduled for completion by September 30, 2022. Gen-Probe Incorporated holds several Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with...
The Defense Health Agency (DOD) awarded a $320,542.72 delivery order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for APTIMA SARS-COV-2 ASSAY, EUA, 250-TEST. The firm fixed price contract has a period of performance starting on January 20, 2022 through February 18, 2022 and will be performed in Portsmouth, Virginia. Gen-Probe Incorporated will provide its APTIMA SARS-COV-2 ASSAY test kits, which have received Emergency Use Authorization from the U.S. Food and...
This is a firm fixed-price delivery order awarded by the Defense Health Agency to Gen-Probe Incorporated, a for-profit medical diagnostics company, for the provision of COVID-19 reagents. The contract has a ceiling value of $965,100.00 and an ultimate completion date of November 1, 2020. The contract was awarded under the Coronavirus COVID-19 national interest action code and is not set aside. Gen-Probe is a specialized supplier of molecular diagnostic testing systems, assays, and related...
The Defense Health Agency (DOD) awarded a $339,005 purchase order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division to provide COVID-19 test kits and supplies. The place of performance is Bethesda, Maryland and the contract period is from January 28, 2022 to February 10, 2022. The pricing structure is firm fixed price. Gen-Probe Incorporated will supply coronavirus disease 2019 test kits and related materials to the Defense Health Agency to support continued testing...
<p>The Defense Health Agency (DOD) awarded a $745,185 purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for APTIMA SARS-COV-2 ASSAY KITS. The firm fixed price contract will provide coronavirus COVID-19 testing kits to support national interest actions in Japan, with performance taking place from May 10, 2022 through June 1, 2022.</p>
This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Gen-Probe Incorporated, a medical diagnostics company, for the provision of SARS COVID-19 test kits. The contract has a potential value of $317,100.00 and a completion date of June 18, 2020. The contract is not designated as a set-aside. Gen-Probe Incorporated has previously provided various medical diagnostic products and services to federal agencies, including the Defense Health...
This federal contract award was made by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the provision of COVID-19 reagents. The Firm Fixed Price Delivery Order has a ceiling value of $319,600.00 and an ultimate completion date of February 26, 2021. Gen-Probe is an experienced federal contractor, holding multiple Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with defense and civilian agencies to supply a range of molecular...